Saul A Rosenberg
Academic Appointments
- Professor Emeritus, Medicine - Oncology
- Emeritus Faculty, Acad Council, Medicine - Oncology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Lymphoma Clinic 875 Blake Wilbur Dr Clinic C Stanford, CA 94305 Tel Work (650) 725-6455 Fax (650) 725-1420
- Academic Offices
Personal Information Email Tel (650) 725-6455Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Lymphoma
- Hodgkin's Disease
- Hodgkin's Disease - Hematology
- Hodgkin's Disease - Medical Oncology
- Lymphoma
- Medical Oncology
Professional Education
| Residency: | Peter Bent Brigham Hospital MA (1961) |
| Residency: | Peter Bent Brigham Hospital MA (1957) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1973) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1961) |
| Fellowship: | Memorial Sloan-Kettering Cancer Center, NY USA (1958) |
| Internship: | University Hospitals of Cleveland OH (1954) |
Scientific Focus
Current Research Interests
Clinical Investigations of Hodgkins Disease: Current trials are defining (1) the utility of an abbreviated chemotherapy and minimal radiotherapy for favorable, clinically-staged patients with the disease; (2) the development of new dose-intensive chemotherapy programs for unfavorable and advanced disease. In collaboration with radiotherapists and Dr. Sandra Horning, careful retrospective and prospective studies of fertility, cardiopulmonary and secondary neoplasms are being done.
Clinico-laboratory Studies in the Non-Hodgkins Lymphomas: A major research interest of Dr. Rosenberg is the clinical, pathological and molecular basis of diagnosis, evolution, treatment and understanding of the non-Hodgkins lymphomas. This research is performed by a large interdisciplinary group of investigators which Dr. Ronald Levy directs.
Publications
- Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience. Int J Radiat Oncol Biol Phys. 2011; (5): 1374-9
- Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue. Leuk Lymphoma. 2010; (7): 1356-9
- Follicular lymphoma revisited. J Clin Oncol. 2008; (4): 515-6
- Lymphography: a great advance, abandoned. J Clin Oncol. 2008; (35): 5662-3
- Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. J Clin Oncol. 2007; (25): 3902-7
- Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: Diagnostic and therapeutic challenges. Ann Hematol. 2006; (11): 817-20
Help
Trial Administration